Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Informed Medical Communications (IMC) is a specialized medical communications agency that provides peer-to-peer medical education and speaker bureau services to the pharmaceutical and biotechnology industries. The company focuses on developing strategic scientific content and managing high-impact educational programs designed to engage healthcare professionals. IMC is recognized for its use of proprietary technology platforms to ensure regulatory compliance and operational efficiency in large-scale speaker programs. In 2012, IMC was acquired by UDG Healthcare and integrated into its Ashfield Healthcare Communications division. It now operates as part of Inizio, a global leader in healthcare commercialization and medical affairs services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Informed Medical Communications.